Kirsch B, DuBois J, Chadha D. A Multi-Center, Open-Label Study to Assess Pharmacokinetics (PK), Safety and Tolerability of Sofpironium Bromide Gel, 15% Applied Topically to Children and Adolescents, ≥9 to <17 Years of Age, with Axillary Hyperhidrosis. J of Skin [Internet]. 2019 Nov. 9 [cited 2024 Jul. 3];3:S54. Available from: https://jofskin.org/33014/index.php/skin/article/view/782